Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study.
about
Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysisA Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer RiskMetformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer.The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link.Effect of rTsP53 on the M1/M2 activation of bone-marrow derived macrophage in vitroStress-Related Signaling Pathways in Lethal and Nonlethal Prostate CancerA Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study.Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era.ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents.Involvement of IGF-2, IGF-1R, IGF-2R and PTEN in development of human tooth germ - an immunohistochemical study.Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis.Prolonged Response to an IGF-1 Receptor Antibody in a Patient with Metastatic Castration Prostate Cancer with Neuroendocrine Differentiation.Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgery.A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus.MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nuclear translocation via regulating PI3K/Akt pathway.
P2860
Q30235013-FA7839A9-DB4E-4B76-B44F-AD096D468E7AQ31049602-A90E0F61-B312-4A38-A896-6A2F2E5B2554Q33921635-72A5DC86-FEA9-4DA9-AAC0-C688205A8B15Q35609517-74A93BC7-4E4C-42A9-950E-AD138236FC7EQ36375620-9995B9DC-2176-4BA9-B5E0-41B6927710D1Q36535817-E39ACB62-986D-4DFF-A05C-0AE03A2E3CC2Q36887707-76B05070-8BB2-4E10-9520-42435DEF6F86Q37481246-E56AD5EF-7949-4D50-96D4-1A76F6994162Q37634500-615C159B-BD38-4658-9831-7EF7242891D7Q38883101-8789E75D-A1EE-4482-9AD4-504E6E69C3CFQ39667374-66C6E829-7EBD-47E6-9D95-150300C49986Q40721274-657A9423-389D-4F3A-BD2C-2C0C54D78A44Q43067025-7FE4F669-67AA-4B9C-A1C7-167DE9775787Q47758797-31C6234A-E130-4506-A513-3222697ED020Q49884540-CE381918-6F81-46D0-B95E-C85A5CA79278Q51566336-D3068F63-1542-49FC-8C3D-002862E5D6CCQ55332538-5B328565-262E-42F1-ACCC-FE153CCFB2C7
P2860
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protein expression of PTEN, in ...... e cancer: a prospective study.
@en
Protein expression of PTEN, in ...... e cancer: a prospective study.
@nl
type
label
Protein expression of PTEN, in ...... e cancer: a prospective study.
@en
Protein expression of PTEN, in ...... e cancer: a prospective study.
@nl
prefLabel
Protein expression of PTEN, in ...... e cancer: a prospective study.
@en
Protein expression of PTEN, in ...... e cancer: a prospective study.
@nl
P2093
P2860
P50
P1476
Protein expression of PTEN, in ...... e cancer: a prospective study.
@en
P2093
Edward Giovannucci
Jennifer A Sinnott
Kathryn L Penney
Ladan Fazli
Martin E Gleave
Michael N Pollak
Michelangelo Fiorentino
Neil E Martin
P2860
P304
P356
10.1158/1055-9965.EPI-13-0349
P577
2013-08-27T00:00:00Z